--- title: "The Cannabist Company Holdings Inc. (CBSTQ.US)" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/CBSTQ.US.md" symbol: "CBSTQ.US" name: "The Cannabist Company Holdings Inc." industry: "Pharmaceuticals" datetime: "2026-04-04T03:30:59.334Z" locales: - [en](https://longbridge.com/en/quote/CBSTQ.US.md) - [zh-CN](https://longbridge.com/zh-CN/quote/CBSTQ.US.md) - [zh-HK](https://longbridge.com/zh-HK/quote/CBSTQ.US.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/CBSTQ.US.md) | [繁體中文](https://longbridge.com/zh-HK/quote/CBSTQ.US.md) # The Cannabist Company Holdings Inc. (CBSTQ.US) | Item | Detail | |------|--------| | Industry | Pharmaceuticals | | Exchange | US Market | | Website | [www.cannabistcompany.com](https://www.cannabistcompany.com) | ## Key Drivers > *AI-analyzed key factors driving this stock's performance* ## Longbridge Financial Score™: D > *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge* > Updated: 2026-04-03T04:30:11.000Z **Overall: D (0.68)** **Industry**: Pharmaceuticals | Metric | Value | |--------|-------| | Industry Ranking | 159 / 188 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. **Multi Score**: D #### Style Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -28.74% | | | Net Profit YoY | -44.25% | | | P/B Ratio | -0.10 | | | Dividend Ratio | 0.00% | | #### Size Score Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 15793996.92 | | | Revenue | 349840000.00 | | #### Multi Score Score: D | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 282.15% | A | | Profit Margin | -51.15% | E | | Gross Margin | 28.67% | C | | Revenue YoY | -28.74% | E | | Net Profit YoY | -44.25% | D | | Total Assets YoY | -30.39% | E | | Net Assets YoY | -737.21% | E | | Cash Flow Margin | -195.49% | D | | OCF YoY | -28.74% | E | | Turnover | 0.54 | C | | Gearing Ratio | 128.51% | E | ```chart-data:radar { "title": "Longbridge Financial Score - The Cannabist Company Holdings Inc.", "chart_type": "radar", "dimensions": [ { "name": "Style Score", "grade": "", "indicators": [ { "name": "Revenue YoY", "value": "-28.74%", "rating": "" }, { "name": "Net Profit YoY", "value": "-44.25%", "rating": "" }, { "name": "P/B Ratio", "value": "-0.10", "rating": "" }, { "name": "Dividend Ratio", "value": "0.00%", "rating": "" } ] }, { "name": "Size Score", "grade": "", "indicators": [ { "name": "Market Cap", "value": "15793996.92", "rating": "" }, { "name": "Revenue", "value": "349840000.00", "rating": "" } ] }, { "name": "Multi Score", "grade": "D", "indicators": [ { "name": "ROE", "value": "282.15%", "rating": "A" }, { "name": "Profit Margin", "value": "-51.15%", "rating": "E" }, { "name": "Gross Margin", "value": "28.67%", "rating": "C" }, { "name": "Revenue YoY", "value": "-28.74%", "rating": "E" }, { "name": "Net Profit YoY", "value": "-44.25%", "rating": "D" }, { "name": "Total Assets YoY", "value": "-30.39%", "rating": "E" }, { "name": "Net Assets YoY", "value": "-737.21%", "rating": "E" }, { "name": "Cash Flow Margin", "value": "-195.49%", "rating": "D" }, { "name": "OCF YoY", "value": "-28.74%", "rating": "E" }, { "name": "Turnover", "value": "0.54", "rating": "C" }, { "name": "Gearing Ratio", "value": "128.51%", "rating": "E" } ] } ] } ``` ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -0.09 | 67/188 | - | - | - | | PB | -0.10 | 202/188 | - | - | - | | PS (TTM) | 0.05 | 3/188 | - | - | - | | Dividend Yield | 0.00% | - | - | - | - | ## Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | | --- | --- | --- | --- | --- | --- | --- | --- | | 01 | Eli Lilly (LLY.US) | A | A | B | E | B | B | | 02 | ROCHE HOLDINGS AG (RHHVF.US) | A | B | B | D | C | B | | 03 | Roche (RHHBY.US) | A | B | B | D | C | B | | 04 | AstraZeneca (AZN.US) | A | B | C | D | C | B | | 05 | NOVARTIS AG (NVS.US) | A | B | C | D | C | B | ## References - [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/CBSTQ.US/overview.md) - [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/CBSTQ.US/norm.md) - [Related News](https://longbridge.com/en/quote/CBSTQ.US/news.md) - [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/CBSTQ.US/filings.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**